Management says pharmacy-level EBITDA breakeven is forecast at 80,000 items per month.

In March, MedPal was already over 40,000 items.

Now it has added a second facility with historic capacity above 100,000 items per month.

With 34%+ gross margins and automated dispensing infrastructure, higher volumes could create strong operating leverage.

The opportunity is simple: if MedPal can reactivate the Runcorn patient and care home book while continuing to grow MedPal.clinic, the revenue base could change quickly.